Repository logo
Communities & Collections
Research Outputs
Fundings & Projects
People
Statistics
New user? Click here to register.Have you forgotten your password?
  1. Home
  2. CRIS
  3. Publications
  4. Tuberculosis in prisons: an integrated prevention and care cascade for a persistent structural epidemic
Details

Tuberculosis in prisons: an integrated prevention and care cascade for a persistent structural epidemic

Journal
Frontiers in Public Health
Date Issued
2026-07-08
Author(s)
Cagua Ordoñez, Jaen  
CENTRO DE INVESTIGACIÓN DE EVIDENCIA, IMPLEMENTACIÓN Y TOMA DE DECISIONES EN SALUD  
Parise Vasco, Juan Marcos  
CENTRO DE INVESTIGACIÓN DE EVIDENCIA, IMPLEMENTACIÓN Y TOMA DE DECISIONES EN SALUD  
Angamarca Iguago, Jaime  
CENTRO DE INVESTIGACIÓN DE EVIDENCIA, IMPLEMENTACIÓN Y TOMA DE DECISIONES EN SALUD  
Fuentes-Tumbaco, Natasha Bella
Simancas Racines, Daniel  
CENTRO DE INVESTIGACIÓN DE EVIDENCIA, IMPLEMENTACIÓN Y TOMA DE DECISIONES EN SALUD  
Type
Article
DOI
10.3389/fpubh.2026.1892055
URL
https://cris.indoamerica.edu.ec/handle/123456789/10163
Abstract
Tuberculosis (TB) remains disproportionately concentrated in prison populations worldwide, driven by overcrowding, poor ventilation, HIV co-infection, delayed diagnosis, treatment interruption, social vulnerability, and weak integration between correctional health services and national TB programs. This structured narrative review synthesizes current evidence across the prison TB prevention and care cascade, including screening, diagnosis, treatment, transmission reduction, TB/HIV integration, surveillance, and continuity after release. We conducted an expert-led narrative synthesis informed by systematic-review principles, distinguishing direct prison-specific evidence from mathematical modeling, policy guidance, systematic reviews, and indirect evidence from adjacent fields such as HIV care and TB infection treatment. Symptom screening alone has limited sensitivity in high-burden prisons. Digital chest radiography with computer-aided detection can improve case detection when linked to confirmatory molecular testing and treatment capacity. Xpert MTB/RIF or Ultra are central to rapid confirmation and rifampicin-resistance detection. Shorter rifamycin-based regimens for TB infection generally achieve higher completion than longer isoniazid-based regimens, while shorter all-oral MDR/RR-TB regimens may offer programmatic advantages but remain insufficiently studied in correctional settings. Ventilation improvement, safer spaces, peer-supported case detection, and integrated TB/HIV services are important components of transmission reduction. Decongestion may have substantial population-level impact, but this conclusion is supported mainly by mathematical modeling and should be interpreted as a projected effect rather than direct prison-specific causal evidence. Post-release continuity remains a major implementation gap, with limited direct evidence for active TB interventions. Sustainable prison TB control requires moving from isolated activities to an integrated, measurable prison–community cascade linking risk-adapted screening, rapid diagnosis, effective treatment, environmental controls, data systems, and confirmed linkage to community care after release. Copyright © 2026 Cagua-Ordoñez, Parise-Vasco, Angamarca-Iguago, Fuentes-Tumbaco and Simancas-Racines.

Investigación Indoamérica

Logo Universidad Tecnológica Indoamérica
  • Accessibility settings
  • Privacy policy
  • End User Agreement
  • Send Feedback

Hosting & Support by

Built with DSpace-CRIS software - Extension maintained and optimized by 4science

COAR Notify